Document Detail

Intraosseous adenosine for the termination of supraventricular tachycardia in an infant.
MedLine Citation:
PMID:  8780485     Owner:  NLM     Status:  MEDLINE    
In recent years, the intraosseous technique has dramatically improved the speed at which vascular access may be achieved in critically ill children, and adenosine has been shown to rapidly convert supraventricular tachycardia to normal sinus rhythm. Until now, no report has demonstrated that this drug may be effectively given by this route in human beings. This case report describes the successful termination of supraventricular tachycardia in an infant with the intraosseous administration of adenosine.
F D Friedman
Related Documents :
15102645 - Cortisol and growth hormone responses to spontaneous hypoglycaemia in infants and child...
16711345 - Psoas abscess secondary to pott's disease--an unusual presentation in a young child.
6617595 - Differential diagnosis of episodic symptoms.
10065565 - Perioperative alimentation in pediatric patients: when to stop, when to start, and what...
19934465 - Estimating the neurocognitive effects of an early intervention program for children wit...
8813305 - Risk factors and fetal outcome in cases of shoulder dystocia compared with normal deliv...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Annals of emergency medicine     Volume:  28     ISSN:  0196-0644     ISO Abbreviation:  Ann Emerg Med     Publication Date:  1996 Sep 
Date Detail:
Created Date:  1996-10-11     Completed Date:  1996-10-11     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8002646     Medline TA:  Ann Emerg Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  356-8     Citation Subset:  AIM; IM    
Department of Emergency Medicine, New England Medical Center, Boston, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenosine / administration & dosage*,  therapeutic use
Anti-Arrhythmia Agents / administration & dosage*,  therapeutic use
Infant, Newborn
Infusions, Intraosseous*
Tachycardia, Supraventricular / drug therapy*
Treatment Outcome
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 58-61-7/Adenosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  College research associates: a program to increase emergency medicine clinical research productivity...
Next Document:  Cerebral gas embolism resulting from inhalation of pressurized helium.